Document Classification

Section Type: RESULTS

Text: In the placebo group, CRP (median) was 3. 16 mg/L (25 % and 75 % quartiles, 1. 90 and 5. 78 mg/L) at baseline and 4. 22 mg/L (25 % and 75 % quartiles, 2. 04 and 6. 25 mg/L) at 6 months ; in the rofecoxib group, CRP was 3. 45 mg/L (25 % and 75 % quartiles, 2. 08 and 5. 78 mg/L) at baseline and 1. 41 mg/L (25 % and 75 % quartiles, 1. 17 and 4. 81 mg/L) at 6 months (P = 0. 03).